KLOTHO NEUROSCIENCES INC (KLTO) Stock Overview
NASDAQ:KLTO - US49876K1034 - Common Stock
KLTO Key Statistics, Chart & Performance
The current stock price of KLTO is 0.7541 USD. In the past month the price decreased by -33.27%.
KLTO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.6 | 366.65B | ||
| AMGN | AMGEN INC | 13.23 | 155.30B | ||
| GILD | GILEAD SCIENCES INC | 14.75 | 141.64B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.96 | 99.72B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.54 | 60.67B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.15B | ||
| ARGX | ARGENX SE - ADR | 73.07 | 41.45B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.25 | 36.69B | ||
| INSM | INSMED INC | N/A | 27.12B | ||
| BNTX | BIONTECH SE-ADR | N/A | 25.26B | ||
| NTRA | NATERA INC | N/A | 22.30B | ||
| BIIB | BIOGEN INC | 8.52 | 19.99B |
Related stock screener links
About KLTO
Company Profile
Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. The company is headquartered in Omaha, Nebraska and currently employs 3 full-time employees. The company went IPO on 2022-04-29. The firm's licensed platforms, namely, a generic drug portfolio and a biosimilar biologics platform uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Its primary focus is the advancement of a sustainable portfolio of cell and gene therapy product candidates for age-associated neurologic diseases, both rare orphan diseases and diseases in larger patient populations. The firm's two lead gene therapy product candidates are KLTO-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and KLTO-202 (AAVmyo-Des-sKL) gene therapy product for the treatment and prevention of Lou Gehrig’s disease (amyotrophic lateral sclerosis).
Company Info
KLOTHO NEUROSCIENCES INC
13576 Walnut Street, Suite A
Omaha NEBRASKA US
Employees: 3
Phone: 18339316330
KLOTHO NEUROSCIENCES INC / KLTO FAQ
What is the stock price of KLOTHO NEUROSCIENCES INC today?
The current stock price of KLTO is 0.7541 USD. The price increased by 0.71% in the last trading session.
What is the ticker symbol for KLOTHO NEUROSCIENCES INC stock?
The exchange symbol of KLOTHO NEUROSCIENCES INC is KLTO and it is listed on the Nasdaq exchange.
On which exchange is KLTO stock listed?
KLTO stock is listed on the Nasdaq exchange.
What is KLOTHO NEUROSCIENCES INC worth?
KLOTHO NEUROSCIENCES INC (KLTO) has a market capitalization of 39.74M USD. This makes KLTO a Nano Cap stock.
How many employees does KLOTHO NEUROSCIENCES INC have?
KLOTHO NEUROSCIENCES INC (KLTO) currently has 3 employees.
What are the support and resistance levels for KLOTHO NEUROSCIENCES INC (KLTO) stock?
KLOTHO NEUROSCIENCES INC (KLTO) has a support level at 0.74 and a resistance level at 0.86. Check the full technical report for a detailed analysis of KLTO support and resistance levels.
Should I buy KLOTHO NEUROSCIENCES INC (KLTO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KLTO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KLTO, evaluating the profitability, health, valuation and growth aspects
- KLOTHO NEUROSCIENCES INC (KLTO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KLOTHO NEUROSCIENCES INC (KLTO) Sales and EPS estimates to see what analysts future expectations are.
- KLOTHO NEUROSCIENCES INC (KLTO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KLOTHO NEUROSCIENCES INC (KLTO) Insider and Institutional Ownership to learn about the owners and their transactions.
- KLOTHO NEUROSCIENCES INC (KLTO) Stock Chart to make your own analysis
- KLOTHO NEUROSCIENCES INC (KLTO) Latest news and press-releases to stay up to date.
Does KLOTHO NEUROSCIENCES INC (KLTO) stock pay dividends?
KLTO does not pay a dividend.
What is the Price/Earnings (PE) ratio of KLOTHO NEUROSCIENCES INC (KLTO)?
KLOTHO NEUROSCIENCES INC (KLTO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.45).
What is the Short Interest ratio of KLOTHO NEUROSCIENCES INC (KLTO) stock?
The outstanding short interest for KLOTHO NEUROSCIENCES INC (KLTO) is 11.67% of its float. Check the ownership tab for more information on the KLTO short interest.
KLTO Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to KLTO.
KLTO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KLTO. While KLTO has a great health rating, there are worries on its profitability.
KLTO Financial Highlights
Over the last trailing twelve months KLTO reported a non-GAAP Earnings per Share(EPS) of -0.45. The EPS decreased by -1684.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -104.68% | ||
| ROE | -106.6% | ||
| Debt/Equity | 0 |